AtrimusRx AB

Sollentuna · est. 2016 · website↗

With permits for both community pharmacy and wholesale distribution, we supply hospitals, pharmacies, and patients in Europe with essential medicines that are otherwise unavailable through standard distribution channels.These so-called unlicensed medicines include; alternatives to nationally out-of-stock drugs, newly FDA-approved treatments pending local market launch, substances used in clinical trials, extemporaneous preparations for children with specific excipient allergies, as well as oral solutions tailored for elderly patients with swallowing difficulties.

Share feedback about AtrimusRx AB

What kind?
Or email alex@stackholm.dev.
SurvivalStrongEquity ratio 75%
SectorHealth & life science
Employees2-10LinkedIn, 3 weeks ago4 on LinkedIn
Age10 yearsest. 2016
LanguageSwedish
Open roles0 techof 1 advertised

Filed financials

Filed with a public registry

Filed with Bolagsverket. The legal entity, not the group.

Headcount shrank by 1 person (9%) in 2025.

Fiscal yearRevenueResultEmployeesCashEquityTotal assetsFlags
FY2025100 MSEK1.8 MSEK1021 MSEK45 MSEK59 MSEKNone
FY2024154 MSEK16 MSEK1132 MSEK43 MSEK66 MSEKNone
FY2023297 MSEK41 MSEK710 MSEK47 MSEK106 MSEKNone
FY2022190 MSEK32 MSEK75.7 MSEK36 MSEK59 MSEKNone
FY2021157 MSEK-----None
FY2020139 MSEK-----None
FY201974 MSEK-----None

Open roles right now (0)

Via Arbetsformedlingen.

AtrimusRx AB has 1 other role open.

Registered business activity (SNI)

Filed with a public registry

Standard industry classification codes as filed with Bolagsverket.

Partihandel med medicinsk utrustning och apoteksvaror

Companies like this one

Work here?

Nobody has answered yet. Same questions for every company.

Answer for this company

On the map

Hammarbacken 6A, 191 49 Sollentuna

Address from the company's own site.

Drawn by OpenStreetMap, so it only loads when you ask for it.